LOS ANGELES, CA / ACCESSWIRE / April 30, 2015 / Firstin Wireless Technology Inc. (PINKSHEETS: FINW), is pleased to announce it has entered into a merger and amalgamation agreement with BioNovelus Inc.
BioNovelus Inc. is an Arizona corporation with a portfolio of green sustainable technologies. Their solutions address major global challenges: food and water safety and supply.
BioNovelus Inc. has assembled an experienced management team, Board of Directors and a dynamic team of industry advisors. BioNovelus Inc. has also established a Scientific and Medical Advisory Board to serve the company in various product research, future clinical trial testing and regulatory matters. Near-term growth of BioNovelus Inc. will be accomplished by two means: organic growth through regional distribution partnerships of BioNovelus manufactured products and the acquisition or competitive brands.
The binding amalgamation/merger agreement between Firstin and BioNovelus has the following terms and conditions:
Prior to the amalgamation, Firstin will consolidate its share capital. Shareholders of Firstin Wireless will receive 1 new Firstin share for every 750 Firstin old shares (1:750);
BioNovelus shareholders will receive 7 post-consolidation common shares of Firstin Wireless per BioNovelus share. There is currently 10,000,000 (ten million) common shares issued and outstanding in BioNovelus. BioNovelus shareholders will received collectively a total of seventy million (70,000,000) post-consolidation or new shares of Firstin Wireless. Management and directors of BioNovelus are expected to own directly or indirectly 84.5% of the 70 million shares to be issued.
Firstin Wireless will also change its name to BioNovelus Inc. Mr. Jay Pignatello has also agreed to resign following the closing of the transaction in favor of the proposed new President and CEO, Mr. Jean Ekobo.
Following the closing of the transaction the new Board of Directors will consist of Mr. Jean Ekobo, President and Director and Mr. Douglas Collins, Director. They will be joined by 3 other individuals who will act as independent directors and who will be identified in a future press release.
The new Management will consist of:
Mr. Jean Ekobo, CEO
Mr. Dan Vallee, COO
Mr. Marvin R. Clarke, CFO
Mr. Richard Hoover, Senior Vice President of Sales & Marketing
Mr. Douglas Collins, Vice President of Sales
Mrs. Nathalie Ekobo, Marketing Manager
Mr. Scott Yenglin, Vice President of Manufacturing
Jean Ekobo, President: Founder of BioNovelus Inc. Jean is the persistent leader of this newly created bioscience organization. He is an accomplished business owner in various successful ventures and won numerous awards over the past 15 years for business development and account management, and for activities in the hospitality industry, including the “Exceptional Competency Visa” awarded by the US Homeland Security Administration to High Achievers in their fields.
Daniel C. Valle, CEO: Dan has over 27 years managing large business enterprises. He is an internationally Accredited Associate of the Institute for Independent Business (IIB), a worldwide business consulting and accreditation organization with over 5,000 Associates in 38 countries. Dan is the founder, President and Principal Consultant, of DCV & Associates, LLC, a general business consulting firm located in Sierra Vista, AZ.
Marvin Clark, CFO: Managing Principal and Chief Economist and Strategist of Monsoon Wealth Management which offers private wealth risk management services to affluent clients and small businesses throughout the US. Monsoon’s major task is employing macroeconomic top-down research and analysis, formulating strategic investment thesis across debt, equity, and commodity asset classes.
Richard Hoover, SVP for Sales and Marketing: 36 years of experience in water and energy companies. Recently, for a startup technology firm developing and delivering innovative, award winning water treatment technology to purify contaminated water in the oil and gas fields and refining industries. Richard took the company from start up to $100M valuation level in a 5 year period.
Douglas Collins, VP of Sales: As a business strategist, Doug has initiated Brand Development, Capital Acquisition, End Game Scenarios, and Strategic Business Plans for his clientele. He has worked in over 56+ countries around the world bringing a global perspective to his sales strategies. Doug has extensive sales experience in the environmental industry and has served in senior management roles with global entities including Buderus Group, Diemme SpA, Klein GmbH, Culligan USA and Clean Energy Technologies.
Nathalie Ekobo, Marketing Manager: 25+ years as an international Marketing and Sales Manager where she designed and implemented marketing campaigns to create distribution channels and provide distributors with adequate marketing support generating millions for several French and American companies. As a Communication Manager and Corporate Trainer/Speaker, she has done presentations in over 12 countries. Her specialties include: Integrated Marketing Strategy, Campaign Development and Implementation and Branding.
Scott Yenglin, VP of Manufacturing: 20+ years working as a safety consultant for several Fortune 500 and 100 companies including General Motors, Jones Lang LaSalle and Honeywell Aerospace. He has also launched several private small business interests over his career, offering his services to companies like Henry Ford Hospital and EDS.
About BioNovelus Inc.
BioNovelus, Inc. is a bioscience company building a portfolio of green technologies. The solutions address major global challenges: food safety and supply, and water safety and supply.
Additional Information
For additional information, please contact:
Doug Collins, VP of Sales, BioNovelus, Inc.:
602-888-3424
Info@BioNovelus.com
Forward-Looking Statements
This news release includes forward-looking statements covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events, they are subject to various risks and uncertainties and actual results for fiscal year 2015 and beyond could differ materially from the Company’s current expectations.
Forward-looking statements are identified by words such as “anticipates,” “projects,” “expects,” “plans,” “intends,” “believes,” “estimates,” “targets,” and other similar expressions that indicate trends and future events.
Factors that could cause the Company’s results to differ materially from those expressed in forward-looking statements include, without limitation, variation in demand and acceptance of the Company’s products and services, the frequency, magnitude and timing of paper and other raw-material-price changes, general business and economic conditions beyond the Company’s control, timing of the completion and integration of acquisitions, the consequences of competitive factors in the marketplace including the ability to attract and retain customers, results of continuous improvement and other cost-containment strategies, and the Company’s success in attracting and retaining key personnel. The Company undertakes no obligation to revise or update forward-looking statements as a result of new information, since these statements may no longer be accurate or timely.
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, and are subject to Rule 3B-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this press release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.
SOURCE: Firstin Wireless Technology Inc.
ReleaseID: 428367
